Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 Jan;59(1):235–242.

Studies of the in vivo synthesis and catabolism of serum amyloid P component (SAP) in the mouse.

M L Baltz, R F Dyck, M B Pepys
PMCID: PMC1577182  PMID: 3882285

Abstract

The production of mouse serum amyloid P component (SAP), a major acute phase protein of liver origin, was studied immunocytochemically using the peroxidase staining technique. SAP was not detectable in the cytoplasm of hepatocytes from normal, unstimulated mice, nor was it observed before 24 h after an acute phase stimulus. 125I-labelled mouse SAP was cleared from the plasma in vivo with a half-life of 7.0-8.25 h in all animals studied including: normal mice of different strains with different genetically determined plasma SAP concentrations; mice undergoing acute phase responses with greatly elevated plasma SAP levels and mice with casein-induced amyloidosis. The circulating level of SAP is thus independent of its rate of clearance and catabolism and is determined by the rate of synthesis and/or secretion of SAP.

Full text

PDF
238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. K., Mole J. E. Large scale isolation and partial primary structure of human plasma amyloid P-component. Ann N Y Acad Sci. 1982;389:216–234. doi: 10.1111/j.1749-6632.1982.tb22139.x. [DOI] [PubMed] [Google Scholar]
  2. Baltz M. L., Dyck R. F., Pepys M. B. Amyloid P-component in mice injected with casein: identification in amyloid deposits and in the cytoplasm of hepatocytes. Immunology. 1980 Sep;41(1):59–66. [PMC free article] [PubMed] [Google Scholar]
  3. Baltz M. L., Gomer K., Davies A. J., Evans D. J., Klaus G. G., Pepys M. B. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains. Clin Exp Immunol. 1980 Feb;39(2):355–360. [PMC free article] [PubMed] [Google Scholar]
  4. Cathcart E. S., Wollheim F. A., Cohen A. S. Plasma protein constituents of amyloid fibrils. J Immunol. 1967 Aug;99(2):376–385. [PubMed] [Google Scholar]
  5. Cohen A. S., Shirahama T. Animal model for human disease: spontaneous and induced amyloidosis. Am J Pathol. 1972 Aug;68(2):441–444. [PMC free article] [PubMed] [Google Scholar]
  6. Courtoy P. J., Lombart C., Feldmann G., Moguilevsky N., Rogier E. Synchronous increase of four acute phase proteins synthesized by the same hepatocytes during the inflammatory reaction: a combined biochemical and morphologic kinetics study in the rat. Lab Invest. 1981 Feb;44(2):105–115. [PubMed] [Google Scholar]
  7. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  8. HUNTER W. M., GREENWOOD F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962 May 5;194:495–496. doi: 10.1038/194495a0. [DOI] [PubMed] [Google Scholar]
  9. JANIGAN D. T. EXPERIMENTAL AMYLOIDOSIS: STUDIES WITH A MODIFIED CASEIN METHOD, CASEIN HYDROLYSATE AND GELATIN. Am J Pathol. 1965 Jul;47:159–171. [PMC free article] [PubMed] [Google Scholar]
  10. Jensson O., Björnsson O. G., Arnason A., Birgisdóttir B., Pepys M. B. Serum amyloid P-component and C-reactive protein in serum of healthy Icelanders and members of an Icelandic family with macroglobulinaemia. Acta Med Scand. 1982;211(5):341–345. doi: 10.1111/j.0954-6820.1982.tb01959.x. [DOI] [PubMed] [Google Scholar]
  11. Kushner I., Broder M. L., Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest. 1978 Feb;61(2):235–242. doi: 10.1172/JCI108932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kushner I., Feldmann G. Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit. J Exp Med. 1978 Aug 1;148(2):466–477. doi: 10.1084/jem.148.2.466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mortensen R. F., Beisel K., Zeleznik N. J., Le P. T. Acute-phase reactants of mice. II. Strain dependence of serum amyloid P-component (SAP) levels and response to inflammation. J Immunol. 1983 Feb;130(2):885–889. [PubMed] [Google Scholar]
  14. Oliveira E. B., Gotschlich C., Liu T. Y. Primary structure of human C-reactive protein. J Biol Chem. 1979 Jan 25;254(2):489–502. [PubMed] [Google Scholar]
  15. Oliveira E. B., Gotschlich E. C., Liu T. Y. Primary structure of human C-reactive protein. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3148–3151. doi: 10.1073/pnas.74.8.3148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Osmand A. P., Friedenson B., Gewurz H., Painter R. H., Hofmann T., Shelton E. Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Natl Acad Sci U S A. 1977 Feb;74(2):739–743. doi: 10.1073/pnas.74.2.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pepys M. B., Baltz M. L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212. doi: 10.1016/s0065-2776(08)60379-x. [DOI] [PubMed] [Google Scholar]
  18. Pepys M. B., Baltz M., Gomer K., Davies A. J., Doenhoff M. Serum amyloid P-component is an acute-phase reactant in the mouse. Nature. 1979 Mar 15;278(5701):259–261. doi: 10.1038/278259a0. [DOI] [PubMed] [Google Scholar]
  19. Pepys M. B., Dash A. C., Ashley M. J. Isolation of C-reactive protein by affinity chromatography. Clin Exp Immunol. 1977 Oct;30(1):32–37. [PMC free article] [PubMed] [Google Scholar]
  20. Pepys M. B., Dash A. C. Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet. 1977 May 14;1(8020):1029–1031. doi: 10.1016/s0140-6736(77)91260-0. [DOI] [PubMed] [Google Scholar]
  21. Pepys M. B., Dash A. C., Markham R. E., Thomas H. C., Williams B. D., Petrie A. Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum. Clin Exp Immunol. 1978 Apr;32(1):119–124. [PMC free article] [PubMed] [Google Scholar]
  22. Pepys M. B. Isolation of serum amyloid P-component (protein SAP) in the mouse. Immunology. 1979 Jul;37(3):637–641. [PMC free article] [PubMed] [Google Scholar]
  23. Ram J. S., DeLellis R. A., Glenner G. G. Amyloid. 8. On strain variability in experimental murine amyloidosis. Proc Soc Exp Biol Med. 1969 Feb;130(2):462–464. doi: 10.3181/00379727-130-33580. [DOI] [PubMed] [Google Scholar]
  24. Skinner M., Sipe J. D., Yood R. A., Shirahama T., Cohen A. S. Characterization of P-component (AP) isolated from amyloidotic tissue: half-life studies of human and murine AP. Ann N Y Acad Sci. 1982;389:190–198. doi: 10.1111/j.1749-6632.1982.tb22137.x. [DOI] [PubMed] [Google Scholar]
  25. Tatsuta E., Sipe J. D., Shirahama T., Skinner M., Cohen A. S. Colchicine inhibition of serum amyloid protein SAA and SAP synthesis in primary mouse liver cell cultures. Arthritis Rheum. 1984 Mar;27(3):349–352. doi: 10.1002/art.1780270317. [DOI] [PubMed] [Google Scholar]
  26. Tatsuta E., Sipe J. D., Shirahama T., Skinner M., Cohen A. S. Different regulatory mechanisms for serum amyloid A and serum amyloid P synthesis by cultured mouse hepatocytes. J Biol Chem. 1983 May 10;258(9):5414–5418. [PubMed] [Google Scholar]
  27. Westermark P., Shirahama T., Skinner M., Brun A., Cameron R., Cohen A. S. Immunohistochemical evidence for the lack of amyloid P component in some intracerebral amyloids. Lab Invest. 1982 May;46(5):457–460. [PubMed] [Google Scholar]
  28. Westermark P., Skinner M., Cohen A. S. The P-component of amyloid of human islets of langerhans. Scand J Immunol. 1975;4(1):95–97. doi: 10.1111/j.1365-3083.1975.tb02604.x. [DOI] [PubMed] [Google Scholar]
  29. de Beer F. C., Hind C. R., Fox K. M., Allan R. M., Maseri A., Pepys M. B. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J. 1982 Mar;47(3):239–243. doi: 10.1136/hrt.47.3.239. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES